🇺🇸 FDA
Patent

US 9630914

Multitarget FAAH and COX inhibitors and therapeutical uses thereof

granted A61PA61P1/02A61P1/04

Quick answer

US patent 9630914 (Multitarget FAAH and COX inhibitors and therapeutical uses thereof) held by The Regents of the University of California expires Mon Apr 20 2037 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.

Key facts

Applicant
The Regents of the University of California
Grant date
Tue Apr 25 2017 00:00:00 GMT+0000 (Coordinated Universal Time)
Expiration
Mon Apr 20 2037 00:00:00 GMT+0000 (Coordinated Universal Time)
Claims
6
CPC classes
A61P, A61P1/02, A61P1/04, A61P1/16, A61P1/18